Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
2024 · Acta Pharmaceutica Sinica B · 19 citations
https://doi.org/10.1016/j.apsb.2024.05.028
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
295
Citations
6
h-index
6
i10-index
Wenjuan Luo is an academic researcher from Wenzhou Medical University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Nanoparticle-Based Drug Delivery & Cancer Immunotherapy and Biomarkers. The author has an h-index of 6, co-authored 6 publications.
https://doi.org/10.1016/j.apsb.2024.05.028
https://doi.org/10.1016/j.apsb.2023.08.026
Click to start Chat